Journal Information

Statistics

Special Article

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab

Anakinra, una alternativa potencial en el tratamiento de la infección respiratoria grave por SARS-CoV-2 refractaria a tocilizumab

Luis Figuero-Péreza,b,

,◊, Alejandro Olivares-Hernándeza,b,◊, Roberto A. Escala-Cornejob,c, Eduardo Terán-Bragea,b, Álvaro López-Gutiérreza,b, Juan J. Cruz-Hernándeza,b

a Servicio de Oncología Médica, Complejo Universitario de Salamanca, Salamanca, Spain

b Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

c Servicio de Oncología Médica, Complejo Universitario de Ávila, Ávila, Spain

Read

4409

Times
was read the article

146

Total PDF

4262

Total HTML

Total EPUB

Share statistics

Article information

ISSN: 21735743
Original language: English

The statistics are updated each day

Year/Month	Html	Pdf	Epub	Total

2022 January	235	2	0	237
2021 December	386	7	1	394
2021 November	122	6	0	128
2021 October	196	3	0	199
2021 September	111	3	0	114
2021 August	123	7	0	130
2021 July	91	2	0	93
2021 June	121	6	0	127
2021 May	602	12	0	614
2021 April	1276	13	0	1289
2021 March	188	7	0	195
2021 February	200	3	0	203
2021 January	278	18	0	296
2020 December	148	21	0	169
2020 November	95	22	0	117
2020 October	90	14	0	104

Show all

Subscribe to our newsletter